# OnCo record paper-binnewies-tumor-immune-microenvironment-natmed-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-binnewies-tumor-immune-microenvironment-natmed-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-binnewies-tumor-immune-microenvironment-natmed-2018" ;
  schema:name "Binnewies 2018: understanding the tumour immune microenvironment for effective therapy"@en ;
  schema:description "A review that sorted tumours by where their immune cells sit, inflamed and infiltrated, infiltrated but excluded, or immune-poor, and argued that this classification should guide which immunotherapy a patient receives."@en ;
  schema:url <https://onco.cc/key-papers/paper-binnewies-tumor-immune-microenvironment-natmed-2018/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-018-0014-x> ;
  schema:sameAs <https://doi.org/10.1038/s41591-018-0014-x> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Binnewies M, Roberts EW, Kersten K, et al." ;
  onco:related <https://onco.cc/key-papers/paper-thorsson-immune-landscape-of-cancer-immunity-2018/>, <https://onco.cc/key-papers/paper-tumeh-pd1-adaptive-immune-resistance-nature-2014/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> ;
  onco:terms <https://onco.cc/terms/cold-vs-hot/>, <https://onco.cc/terms/tils/>, <https://onco.cc/terms/immune-system/> .
